Claritas Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Kalytera is pioneering the development of a next generation of cannabinoid therapeutics. Kalytera is focused first on developing a new class of proprietary cannabidiol (“CBD”) therapeutics.
Claritas Pharmaceuticals has raised $900k across 1 funding round on record, the most recent a Post-IPO Debt of $900k announced in Oct 2021.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Claritas Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Oct 2021.
Claritas Pharmaceuticals Funding Rounds
Claritas Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Claritas Pharmaceuticals Funding Compared to Other Biotechnology Startups
Claritas Pharmaceuticals' latest round of $900k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Claritas Pharmaceuticals in Biotechnology and San Rafael
Companies Similar to Claritas Pharmaceuticals
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Claritas Pharmaceuticals Funding FAQs
What does Claritas Pharmaceuticals do?
Kalytera is pioneering the development of a next generation of cannabinoid therapeutics. Kalytera is focused first on developing a new class of proprietary cannabidiol (“CBD”) therapeutics.
How much funding has Claritas Pharmaceuticals raised?
Claritas Pharmaceuticals has raised $900k across 1 round on record. The most recent is a Post-IPO Debt of $900k announced in Oct 2021.
When did Claritas Pharmaceuticals last raise funding?
Claritas Pharmaceuticals' most recent funding round on record is a Post-IPO Debt of $900k, announced in Oct 2021.
Who is the CEO of Claritas Pharmaceuticals?
Bob Farrell is listed as CEO at Claritas Pharmaceuticals.
Where is Claritas Pharmaceuticals headquartered?
Claritas Pharmaceuticals is based in San Rafael, California, United States.
How many employees does Claritas Pharmaceuticals have?
Claritas Pharmaceuticals is in the 11-50 employee band.
How does Claritas Pharmaceuticals' funding compare to other Biotechnology startups?
Claritas Pharmaceuticals' latest round of $900k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Claritas Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Claritas Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.